Atlas Trials

Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis

Clinical trial NCT05943899 · COMPLETED

Trial details

NCT number
NCT05943899
Sponsor
Diabetes Foundation, India
Status
COMPLETED
Study type
OBSERVATIONAL
Type2diabetes
Start date
2020-02-01
Primary completion
2022-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.